The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]

Meng Kong, Chuanli Zhou, Xuexiao Ma Department of Spinal Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong Province 266000, People’s Republic of ChinaCorrespondence: Xuexiao MaDepartment of Spinal Surgery, Affiliated Hospital of Qingdao University, No. 59, Hai Er Road,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kong M, Zhou C, Ma X
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/11f1213e1acb49d1b2a31f0d43e5c9e9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:11f1213e1acb49d1b2a31f0d43e5c9e9
record_format	dspace
spelling	oai:doaj.org-article:11f1213e1acb49d1b2a31f0d43e5c9e92021-12-02T06:46:29ZThe Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]1178-1998https://doaj.org/article/11f1213e1acb49d1b2a31f0d43e5c9e92020-01-01T00:00:00Zhttps://www.dovepress.com/the-application-of-vertebral-augmentation-procedures-and-teriparatide--peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Meng Kong, Chuanli Zhou, Xuexiao Ma Department of Spinal Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong Province 266000, People’s Republic of ChinaCorrespondence: Xuexiao MaDepartment of Spinal Surgery, Affiliated Hospital of Qingdao University, No. 59, Hai Er Road, Qingdao, Shandong Province 266000, People’s Republic of ChinaTel + 86 532 18661807895Email ma_xuexiao@126.com With the attempt to explore a reasonable treatment strategy, we presented the positive effectiveness of teriparatide (TPTD) administration in improving quality of life (QOL) and reducing the incidence of new vertebral compression fractures (NVCFs) after percutaneous kyphoplasty (PKP). 1 Being interested with the comment opinion proposed by Zhou et al, we would like to put forward our views.Short-term (eg pain relief, restoration of mechanical stability, mobility improvement and fracture healing) and long-term achievements (eg progressive QOL improvement and prevention of NVCFs) need to be realized in strategies for patients who suffered osteoporotic vertebral compression fractures (OVCFs). 2,3 Vertebral augmentation procedures (VAP), ie percutaneous vertebroplasty (PVP) and/or PKP, is a minimally invasive therapy adopted in the treatment of OVCFs with the aim of prior pain alleviation by stabilizing the vertebral fracture and recovery of function by restoring vertebral body height (VBH). 4 Literature reported that PVP/PKP quickly restored patients’ walking ability soon after operation and improved QOL in the early stage ofOVCFs. 5 On the other hand, except for thewell-known complications induced by surgical procedures, 6 recurrent fractures and the adjacent vertebral fractures are important issues related to VAPs. Logistic regression analysis showed that VAP was a risk factor of vertebra refracture because of increased local vertebral stiffness. 7,8 And this procedure has no contribution to bone healing and the treatment of primary disease, ie osteoporosis. Studies have reported high incidence, up to 21.7%, of new symptomatic compression fractures 1 year after percutaneous vertebroplasty. 9   Read the original article by  Kong et al A letter to the editor has been published for this articleKong MZhou CMa XDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 15, Pp 83-85 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Geriatrics RC952-954.6
spellingShingle	Geriatrics RC952-954.6 Kong M Zhou C Ma X The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
description	Meng Kong, Chuanli Zhou, Xuexiao Ma Department of Spinal Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong Province 266000, People’s Republic of ChinaCorrespondence: Xuexiao MaDepartment of Spinal Surgery, Affiliated Hospital of Qingdao University, No. 59, Hai Er Road, Qingdao, Shandong Province 266000, People’s Republic of ChinaTel + 86 532 18661807895Email ma_xuexiao@126.com With the attempt to explore a reasonable treatment strategy, we presented the positive effectiveness of teriparatide (TPTD) administration in improving quality of life (QOL) and reducing the incidence of new vertebral compression fractures (NVCFs) after percutaneous kyphoplasty (PKP). 1 Being interested with the comment opinion proposed by Zhou et al, we would like to put forward our views.Short-term (eg pain relief, restoration of mechanical stability, mobility improvement and fracture healing) and long-term achievements (eg progressive QOL improvement and prevention of NVCFs) need to be realized in strategies for patients who suffered osteoporotic vertebral compression fractures (OVCFs). 2,3 Vertebral augmentation procedures (VAP), ie percutaneous vertebroplasty (PVP) and/or PKP, is a minimally invasive therapy adopted in the treatment of OVCFs with the aim of prior pain alleviation by stabilizing the vertebral fracture and recovery of function by restoring vertebral body height (VBH). 4 Literature reported that PVP/PKP quickly restored patients’ walking ability soon after operation and improved QOL in the early stage ofOVCFs. 5 On the other hand, except for thewell-known complications induced by surgical procedures, 6 recurrent fractures and the adjacent vertebral fractures are important issues related to VAPs. Logistic regression analysis showed that VAP was a risk factor of vertebra refracture because of increased local vertebral stiffness. 7,8 And this procedure has no contribution to bone healing and the treatment of primary disease, ie osteoporosis. Studies have reported high incidence, up to 21.7%, of new symptomatic compression fractures 1 year after percutaneous vertebroplasty. 9   Read the original article by  Kong et al A letter to the editor has been published for this article
format	article
author	Kong M Zhou C Ma X
author_facet	Kong M Zhou C Ma X
author_sort	Kong M
title	The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
title_short	The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
title_full	The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
title_fullStr	The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
title_full_unstemmed	The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
title_sort	application of vertebral augmentation procedures and teriparatide in the treatment of osteoporotic vertebral compression fractures [response to letter]
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/11f1213e1acb49d1b2a31f0d43e5c9e9
work_keys_str_mv	AT kongm theapplicationofvertebralaugmentationproceduresandteriparatideinthetreatmentofosteoporoticvertebralcompressionfracturesnbspresponsetoletter AT zhouc theapplicationofvertebralaugmentationproceduresandteriparatideinthetreatmentofosteoporoticvertebralcompressionfracturesnbspresponsetoletter AT max theapplicationofvertebralaugmentationproceduresandteriparatideinthetreatmentofosteoporoticvertebralcompressionfracturesnbspresponsetoletter AT kongm applicationofvertebralaugmentationproceduresandteriparatideinthetreatmentofosteoporoticvertebralcompressionfracturesnbspresponsetoletter AT zhouc applicationofvertebralaugmentationproceduresandteriparatideinthetreatmentofosteoporoticvertebralcompressionfracturesnbspresponsetoletter AT max applicationofvertebralaugmentationproceduresandteriparatideinthetreatmentofosteoporoticvertebralcompressionfracturesnbspresponsetoletter
_version_	1718399736668487680

The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures&nbsp;[Response to Letter]

Ejemplares similares

The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]